Chiu S H, Huskey S W
Department of Drug Metabolism, Merck Research Laboratories, Rahway, New Jersey 07065, USA.
Drug Metab Dispos. 1998 Sep;26(9):838-47.
Glucuronidation of amines has been shown to exhibit species differences in vitro and in vivo. Substrates for N-glucuronidation can be classified according to the chemical structures of the resulting glucuronides into two groups: compounds that form non-quaternary N-conjugates, and those that form the quaternary counterparts. For compounds of the former class-such as sulfonamides, arylamines, and alicyclic, cyclic, and heterocyclic amines-species differences appear to be less striking and are of a quantitative nature. No one common laboratory animal species used routinely in metabolism research (e.g. rat, mouse, dog, non-human primate, rabbit, and guinea pig) has been shown to be deficient in N-glucuronidation when all of the substrates studied and reported are taken into consideration. The ability of a species to form N-glucuronides is compound-dependent, although rabbit and guinea pig appear to exhibit the highest capacity for this bioconjugation among preclinical species. For tertiary amines, most notably the tricyclic antidepressant and antihistamine drugs, N-glucuronidation is commonly observed in non-human primates and man. There are examples, however, of quaternary glucuronidation occurring in lower animal species. In exploring species differences in amine conjugation in vivo, it is noted that the apparent absence of N-glucuronides in animal urine may not reflect the inability of that species to form such conjugates, since the N-glucuronides may be excreted in bile. Problems such as degradation or low recoveries commonly encountered in isolation and identification of in vivo metabolites further complicate the interpretation of data. Because of the wide range of pKa values exhibited by various classes of amines, caution also should be exercised for in vitro studies since incubation conditions for N-glucuronidation often are substrate- and species-dependent. Explanations for the species differences observed in N-glucuronidation appear to be emerging as rapid advances are made in the understanding of the glucuronosyltransferases at the molecular level. More information, however, remains to be gathered from the glucuronosyltransferase genes of animal species other than humans before a better understanding of species differences in N-glucuronidation can be achieved.
胺的葡萄糖醛酸化在体外和体内均表现出种属差异。N - 葡萄糖醛酸化的底物可根据生成的葡萄糖醛酸苷的化学结构分为两类:形成非季铵N - 共轭物的化合物和形成季铵对应物的化合物。对于前一类化合物,如磺胺类、芳胺类以及脂环族、环状和杂环胺类,种属差异似乎不那么显著,且属于数量性质的差异。当考虑到所有已研究和报道的底物时,在代谢研究中常规使用的任何一种常见实验动物物种(如大鼠、小鼠、狗、非人灵长类动物、兔子和豚鼠)均未显示出N - 葡萄糖醛酸化缺陷。一个物种形成N - 葡萄糖醛酸苷的能力取决于化合物,但在临床前物种中,兔子和豚鼠似乎表现出最高的这种生物共轭能力。对于叔胺,最显著的是三环类抗抑郁药和抗组胺药,在非人灵长类动物和人类中通常观察到N - 葡萄糖醛酸化。然而,也有在低等动物物种中发生季铵葡萄糖醛酸化的例子。在探索体内胺共轭的种属差异时,需要注意的是,动物尿液中明显不存在N - 葡萄糖醛酸苷可能并不反映该物种无法形成此类共轭物,因为N - 葡萄糖醛酸苷可能通过胆汁排泄。在体内代谢物的分离和鉴定中常见的降解或回收率低等问题,进一步使数据解释复杂化。由于各类胺表现出广泛的pKa值范围,体外研究也应谨慎,因为N - 葡萄糖醛酸化的孵育条件通常取决于底物和物种。随着在分子水平上对葡萄糖醛酸转移酶的理解取得快速进展,对N - 葡萄糖醛酸化中观察到的种属差异的解释似乎正在出现。然而,在更好地理解N - 葡萄糖醛酸化的种属差异之前,仍需从除人类以外的动物物种的葡萄糖醛酸转移酶基因中收集更多信息。